SPPI  valuation analysis

Name: Spectrum Pharmaceuticals Inc
Description: Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Mar 17, 2022
Market cap: $109.82M (1406th)
Sales(TTM): $94.06 (1408th)
Earnings(TTM): -$118.79M (1356th)

FFER: 0.21*
Actual price: $0.71
* Earnings were reported Aug 10, 2022 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
Spectrum Pharmaceuticals Inc
"Biotechnology" industry
Sales / MarketCap
Spectrum Pharmaceuticals Inc
"Biotechnology" industry
Book / MarketCap
Spectrum Pharmaceuticals Inc
"Biotechnology" industry
Equity / Assets
Spectrum Pharmaceuticals Inc
"Biotechnology" industry